when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Moderna, Inc. ($MRNA) · news · pharmadog

← back to Moderna, Inc.

News mentioning $MRNA

171 stories

Aug 27, 26CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreakfiercebiotech

Aug 27, 26STAT+: The mystery of Moderna’s magic algorithmstat

Aug 27, 26CAR Ts will only treat autoimmune diseases if we can scale deliverybiospace

Aug 26, 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedbiospace

Aug 25, 26STAT+: How Trump’s funding cuts are reshaping the health systemstat

Aug 25, 26With mRNA back in the spotlight, tRNA shows potential to treat genetic diseasefiercebiotech

Aug 25, 26STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and morestat

Aug 24, 26STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and morestat

Aug 24, 26STAT+: Inside Moderna and Merck’s cancer vaccine triumphstat

Aug 24, 26Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alonebiospace

Aug 21, 26Capricor investor calls for change as company awaits decision on Duchenne candidatebiospace

Aug 21, 26STAT+: HHS document offers new clues to Kennedy’s vaccine plansstat

Aug 21, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Aug 21, 26STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and morestat

Aug 20, 26STAT+: FDA approves Ultragenyx gene therapystat

Aug 20, 26Contrasting legal decisions on gender-affirming carestat

Aug 20, 26STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and morestat

Aug 20, 26Merck’s Moderna-partnered vaccine success clears view of post-Keytruda futurebiospace

Aug 20, 26STAT+: One of the most consequential years for cancer treatment, everstat

Aug 20, 26Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impactfiercebiotech

Aug 20, 26Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a studystat

Aug 20, 267 biopharma M&A deals where layoffs followedbiospace

Aug 19, 26Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analystsbiospace

Aug 19, 26STAT+: Experts scrutinize Huidagene’s disclosures after patient deathstat

Aug 19, 26STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approvalstat

Aug 19, 26STAT+: American Cancer Society cancels alcohol industry fundraiserstat

Aug 19, 26STAT+: Brain organoids, kept alive more than five years, matured like human brainsstat

Aug 19, 2611 companies hiring in New Jerseybiospace

Aug 19, 26Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goalbiospace

Aug 19, 26STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and morestat

← prevpage 3 of 6next →